The Journal of Allergy and Clinical Immunology
Volume 121, Issue 5 , Pages 1126-1132.e7, May 2008

Nasal challenge with allergen leads to maxillary sinus inflammation

Section of Otolaryngology–Head and Neck Surgery, the Pritzker School of Medicine, the University of Chicago, Chicago, Ill

Received 23 November 2007; received in revised form 29 January 2008; accepted 12 February 2008. published online 27 March 2008.

Background

Allergic rhinitis and chronic rhinosinusitis are both characterized by chronic inflammation.

Objective

We sought to investigate the effect of nasal allergen challenge on the maxillary sinus and study the effect of premedication with loratadine.

Methods

We performed a double blind, crossover, randomized, placebo-controlled study in 20 allergic subjects out of season. After treatment with either placebo or loratadine (10 mg PO daily) for 1 week, a catheter was inserted into one maxillary sinus and used to lavage the cavity. The subjects then underwent nasal challenge with diluent for the allergen extract, followed by 3 concentrations of grass or ragweed. Nasal and ipsilateral sinus lavages were performed after each challenge and then hourly for 8 hours. Sneezes and symptoms were recorded, and the lavage specimens were evaluated for eosinophils and levels of eosinophil cationic protein, albumin, and histamine. Eleven of the subjects underwent a similar challenge with lactated Ringer's solution.

Results

Compared with the lactated Ringer's solution challenge, allergen challenge resulted in significant increases in most early- and late-phase nasal parameters. Allergen challenge of the nose also led to a significant increase compared with control values in maxillary sinus eosinophils and the levels of albumin, eosinophil cationic protein, and histamine during the late response. Loratadine resulted in significant inhibition of the nasal early response compared with that seen with placebo (P < .05).

Conclusion

These findings suggest that a neural reflex or systemic allergic inflammation is responsible for the sinus inflammatory response and that this inflammatory response might play a role in the development of rhinosinusitis in allergic subjects.

Key words: Allergic rhinitis, chronic rhinosinusitis, allergen challenge, eosinophils, maxillary sinus, reflex

Abbreviations used: ECP, Eosinophil cationic protein, EPR, Early-phase response, LPR, Late-phase response, LR, Lactated Ringer's

 

 Supported by grant AI 45583 from the National Institutes of Health, a research grant from Schering-Plough Corporation, and the McHugh Otolaryngology Research Fund.

 Disclosure of potential conflict of interest: F. M. Baroody has received research support from Alcon and GlaxoSmithKline and has served as an expert witness in litigation over foreign body aspiration in children and subglottic stenosis in children. R. M. Naclerio has consulting arrangements with Allux, Merck, GlaxoSmithKline, and Schering-Plough; has received research support from Merck, Schering-Plough, GlaxoSmithKline, and Genentech; has served as an expert witness in postobstructive pulmonary edema litigation; and has served as a member of the American Academy of Allergy, Asthma & Immunology and the American Academy of Otolaryngology–Head and Neck Surgery. The rest of the authors have declared that they have no conflict of interest.

PII: S0091-6749(08)00360-6

doi:10.1016/j.jaci.2008.02.010

The Journal of Allergy and Clinical Immunology
Volume 121, Issue 5 , Pages 1126-1132.e7, May 2008